Supera
Payments companies reported to CMS as associated with Supera. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Supera, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Supera
These are the largest totals companies reported as associated with Supera. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Damian Grovas Abad | San Juan, PR | Interventional Cardiology | $67,026.17 |
| Prakash Krishnan | New York, NY | Interventional Cardiology | $26,976.91 |
| Matthew Bunte | Kansas City, MO | Interventional Cardiology | $26,269.51 |
| Brian Derubertis | New York, NY | Vascular Surgery | $23,452.69 |
| Christian Bianchi | Loma Linda, CA | Surgery | $22,780.56 |
| James Jenkins | New Orleans, LA | Interventional Cardiology | $20,278.60 |
| Elizabeth Genovese | Philadelphia, PA | Vascular Surgery | $18,324.86 |
| Edwin I Perez Marrero | San Juan, PR | Interventional Cardiology | $16,466.79 |
| Daniella Kadian Dodov | New York, NY | Internal Medicine | $15,845.52 |
| Danielle Bajakian | New York, NY | Vascular Surgery | $14,707.73 |
Prescribed Supera?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.